Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and
safety of odevixibat compared to placebo in children with biliary atresia who have undergone
a Kasai hepatoportoenterostomy.